Share |

MedTech Investing Europe Forum

Tech Bio: Why data-driven technologies are the way forward

February 16, 2023

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes. Here, she talks to Campden FB about starting the medical and cost-efficient benefits of Tech Bio and the rising importance of ‘data donation’…

As a seasoned Tech Bio investor, Hanadi Jabado understands more than most the importance and implications of using data to transform drug discovery and positively change patient outcomes.

A managing partner at innovation investment fund Sana Capital, Hanadi is a passionate advocate for global information sharing and firmly believes the time is now for private investment in early-stage companies that are set to positively shape the future of healthcare.

Venture capital: Ensuring meaningful impact and return on investment

June 23, 2022

Strategic leader Hanadi Jabado talks about how her impactful investment strategy can do good and do well.

Hanadi Jabado is a passionate advocate for entrepreneurship and innovation. When she relocated to the Cambridge ecosystem, her exposure to the best of tech in Europe allowed her to develop a skill for understanding and explaining the needs of early-stage ventures. With successful investments across diverse sectors, she has since seen many startups go on to great things.

The 3D modelling software set to remap the future of cardiac procedures

March 24, 2022

inHEART is pioneering precise digital maps in a process that could revolutionise cardiac care. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and chief executive officer Todor Jeliaskov explains the benefits and potential future applications of the platform.

MedTech innovators present as Campden Wealth returns for the 32nd MTi Forum

March 10, 2022

Companies developing robotic assistance for spine surgery, innovative treatment of cataracts, 3D cardiac modelling software, extracorporeal respiratory support systems and therapy for glaucoma surgery scar prophylaxis will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Forum on June 6 and 7.

Medtronic leverages reach to commercialise partner products in growth markets

October 6, 2021

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

With a global presence in more than 150 countries, Medtronic has a deep footprint in the cardiovascular, medical surgical, neuroscience and diabetes MedTech sectors.

We are pleased to report that in our mission to alleviate pain, restore health and extend life, we have had a positive impact on more than 72 million patients during the year despite pandemic-related challenges.

MedTech Investing Europe Forum returns to virtually connect global investors with healthcare, life sciences and biotech ventures

September 29, 2021

Early-stage solutions for strokes, varicose veins, surgical 3D imaging, wounds, skincare and genomic screenings are among the breakthroughs to be showcased for ambitious investors at the virtual MedTech Investing Europe Forum on 13-14 October.

Amundi explores investments, the medical sector and exit strategies at MedTech Investing Europe Forum

September 14, 2021

The chairman of Supernova Invest, the pioneer and leader of deep tech investment in France, will discuss how investors, families and companies can achieve their goals at the in-person MedTech Investing Europe Forum.

New surgical, nanofiber, sight-saving and robotic solutions at MedTech Investing Forum

August 13, 2021

Cutting-edge venture stage innovations for chronic diseases with billion-dollar market potential will be presented to private investors at the Campden Wealth 31st MedTech Investing Europe Forum on 21-22 September, 2021.

What makes a successful MedTech investment?

July 14, 2021

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

For many investors the strong growth prospects, resilient valuations and defensive nature of healthcare investments make this a very attractive market. Evaluate MedTech calculates $6 billion of venture financing was invested in 2019 and 2020, slightly down from the 2017 high of $7.8 billion.

June 29, 2021

Campden Wealth returned to its programme of in-person meetings after 18-months of disruption throughout the live event industry with its 22nd edition of the Family Office and Investment Forum in London on 23 June.

The forum was a much anticipated coming-together of the close-knit Campden community of single family offices, private wealth holders and business-owning families for the first time in the capital since February 2020.